Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zihuan Antibacterial Gel (紫獾抑菌凝胶) is a topical antimicrobial product developed by Qingdao Tianyu Pharmaceutical Co., Ltd., a subsidiary or affiliate of the Dalian Tianyu Pharmaceutical group. Formulated as a gel for topical application, it is primarily indicated for the management of bacterial skin conditions and the inhibition of pathogenic microorganisms on the skin surface. The product typically contains chlorhexidine acetate as its primary chemical active ingredient, often in combination with traditional Chinese herbal extracts such as *Sophora flavescens* (Ku Shen), *Cnidium monnieri* (She Chuang Zi), and *Phellodendron chinense* (Huang Bai). It is designed to provide broad-spectrum antibacterial activity against common pathogens including *Staphylococcus aureus*, *Escherichia coli*, and *Candida albicans*. In China, it is marketed as an over-the-counter (OTC) sanitary/antibacterial product and is approved for use in maintaining skin hygiene and treating minor skin irritations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Zihuan Antibacterial Gel.